These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 33641055)
1. Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know? Volante M; Mete O; Pelosi G; Roden AC; Speel EJM; Uccella S Endocr Pathol; 2021 Mar; 32(1):154-168. PubMed ID: 33641055 [TBL] [Abstract][Full Text] [Related]
2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D. Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319 [TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
4. Molecular alterations of neuroendocrine tumours of the lung. Rossi G; Bertero L; Marchiò C; Papotti M Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031 [TBL] [Abstract][Full Text] [Related]
5. [Prevalence of the neuroendocrine phenotype in thymus neoplasms]. Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931 [TBL] [Abstract][Full Text] [Related]
6. SATB2 Is Expressed in a Subset of Pulmonary and Thymic Neuroendocrine Tumors. Vrana JA; Boland JM; Terra SBSP; Xie H; Jenkins SM; Mansfield AS; Molina JR; Cassivi SD; Roden AC Am J Clin Pathol; 2021 Oct; 156(5):853-865. PubMed ID: 33978159 [TBL] [Abstract][Full Text] [Related]
7. Comparative immunohistochemical analysis of pulmonary and thymic neuroendocrine carcinomas using PAX8 and TTF-1. Weissferdt A; Tang X; Wistuba II; Moran CA Mod Pathol; 2013 Dec; 26(12):1554-60. PubMed ID: 23787439 [TBL] [Abstract][Full Text] [Related]
8. Comparative genomic hybridization analysis of thymic neuroendocrine tumors. Pan CC; Jong YJ; Chen YJ Mod Pathol; 2005 Mar; 18(3):358-64. PubMed ID: 15272285 [TBL] [Abstract][Full Text] [Related]
9. Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report. Hiro S; Teranishi S; Sawazumi T; Nagaoka S; Sugimoto C; Nagayama H; Segawa W; Kajita Y; Maeda C; Kubo S; Seki K; Tashiro K; Kobayashi N; Yamamoto M; Kudo M; Kaneko T Thorac Cancer; 2023 May; 14(14):1311-1315. PubMed ID: 36941083 [TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine neoplasms of the mediastinum]. Brcic L; Heidinger M; Popper H Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161 [TBL] [Abstract][Full Text] [Related]
11. Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus. Bohnenberger H; Ströbel P Virchows Arch; 2021 Jan; 478(1):129-135. PubMed ID: 33555458 [TBL] [Abstract][Full Text] [Related]
12. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms? Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395 [TBL] [Abstract][Full Text] [Related]
13. Two cases of lung neuroendocrine carcinoma with carcinoid morphology. Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024 [TBL] [Abstract][Full Text] [Related]
14. Lung carcinoid tumors with Diffuse Idiopathic Pulmonary NeuroEndocrine Cell Hyperplasia (DIPNECH) exhibit pejorative pathological features. Prieto M; Chassagnon G; Lupo A; Charpentier MC; Cabanne E; Groussin L; Wislez M; Alifano M; Fournel L Lung Cancer; 2021 Jun; 156():117-121. PubMed ID: 33940544 [TBL] [Abstract][Full Text] [Related]
15. Morphologic and molecular classification of lung neuroendocrine neoplasms. Metovic J; Barella M; Bianchi F; Hofman P; Hofman V; Remmelink M; Kern I; Carvalho L; Pattini L; Sonzogni A; Veronesi G; Harari S; Forest F; Papotti M; Pelosi G Virchows Arch; 2021 Jan; 478(1):5-19. PubMed ID: 33474631 [TBL] [Abstract][Full Text] [Related]
16. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help? Sun TY; Hendifar A; Padda SK Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210 [TBL] [Abstract][Full Text] [Related]
18. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways. Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819 [TBL] [Abstract][Full Text] [Related]
19. Pulmonary neuroendocrine carcinomas. A review of 234 cases and a statistical analysis of 50 cases treated at one institution using a simple clinicopathologic classification. Huang Q; Muzitansky A; Mark EJ Arch Pathol Lab Med; 2002 May; 126(5):545-53. PubMed ID: 11958659 [TBL] [Abstract][Full Text] [Related]
20. Lung and Thymic Carcinoids. Hann CL; Forde PM Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]